$NOVN (-0,1 %) In record mood

Quietly, silently and secretly, the Novartis share price has reached triple digits for the first time in recent days.

Last Friday, they reached a record high of 100.72 francs, in line with the market as a whole. The pharmaceutical company will present figures for the second quarter this Thursday.

The majority of analysts assume that the Basel-based company had such a strong quarter that they will once again raise their guidance for the year as a whole. Novartis had already delighted investors with an upgraded guidance when it presented its figures for the first quarter of the year in April. Since then, the share price has been on a steady upward trend. Many analysts believe that the pharmaceutical company is doing many things right.

Source: awp

Own Buy In:

82.96 CHF